Baystate Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $70.8K | Buy |
1,224
+69
| +6% | +$3.99K | 0.01% | 321 |
|
|
2023
Q3 | $61K | Sell |
1,155
-112
| -9% | -$5.91K | 0.01% | 315 |
|
|
2023
Q2 | $68.5K | Hold |
1,267
| – | – | 0.01% | 296 |
|
|
2023
Q1 | $63.4K | Buy |
1,267
+112
| +10% | +$5.6K | 0.01% | 308 |
|
|
2022
Q4 | $53K | Hold |
1,155
| – | – | ﹤0.01% | 318 |
|
|
2022
Q3 | $45K | Hold |
1,155
| – | – | ﹤0.01% | 315 |
|
|
2022
Q2 | $43K | Hold |
1,155
| – | – | ﹤0.01% | 335 |
|
|
2022
Q1 | $51K | Sell |
1,155
-106
| -8% | -$4.68K | ﹤0.01% | 315 |
|
|
2021
Q4 | $54K | Sell |
1,261
-10
| -0.8% | -$428 | ﹤0.01% | 308 |
|
|
2021
Q3 | $55K | Buy |
1,271
+106
| +9% | +$4.59K | 0.01% | 291 |
|
|
2021
Q2 | $50K | Hold |
1,165
| – | – | ﹤0.01% | 279 |
|
|
2021
Q1 | $45K | Hold |
1,165
| – | – | ﹤0.01% | 270 |
|
|
2020
Q4 | $42K | Hold |
1,165
| – | – | ﹤0.01% | 264 |
|
|
2020
Q3 | $45K | Buy |
1,165
+450
| +63% | +$17.4K | 0.01% | 233 |
|
|
2020
Q2 | $25K | Buy |
715
+705
| +7,050% | +$24.7K | ﹤0.01% | 283 |
|
|
2020
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 609 |
|
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 624 |
|
|
2019
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 580 |
|
|
2019
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 540 |
|
|
2019
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 551 |
|
|
2018
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 556 |
|
|
2018
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 572 |
|
|
2018
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 591 |
|
|
2018
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 551 |
|
|
2017
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 554 |
|
|
2017
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 538 |
|
|
2017
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 557 |
|
|
2017
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 520 |
|